Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
FDA advisory committee supports neratinib approval
Committee members expressed concern about the broadness of the indication proposed by the drug’s maker.
News
iFCG achieves high MRD-negative remission in untreated CLL
NEW YORK – Could a three-course regimen for CLL have a positive affect on treatment?
News
FDA panel backs licensure for epoetin alfa biosimilar
How could a new epoetin alfa biosimilar change care and what are some concerns?
News
FDA advisory committee supports L-glutamine for SCD
L-glutamine powder got the nod from the majority of the FDA’s Oncologic Drugs Advisory Committee for treatment of sickle cell disease.
News
ACT2: Noninvasive vagus nerve stimulation benefits episodic cluster headache
BOSTON – Noninvasive vagus nerve stimulation proved safe and effective for the treatment of episodic cluster headaches.
News
ECG finding predicts AFib in ibrutinib-treated CLL
NEW YORK – Left atrial abnormality as measured by electrocardiogram in ibrutinib-treated patients with chronic lymphocytic leukemia can identify...
News
In good-candidate CLL, don’t wait too long for alloHCT
NEW YORK – Allogeneic hematopoietic stem cell transplantation (alloHCT) using HLA-compatible donors results in excellent long-term progression-...
News
Benefit of rtPA in acute ischemic stroke doesn’t diminish with weight over 100 kg
BOSTON – The results from a pooled analysis of data from three randomized clinical trials support the current recommendations from the American...
News
Ibrutinib response in CLL/SLL less affected by select risk factors
NEW YORK – Risk factors associated with poor outcomes in chronic lymphocytic leukemia/small lymphocytic leukemia patients treated with standard...
News
Intravenous tPA ups mortality in children with acute ischemic stroke
BOSTON – The results show that studies of the efficacy of ischemic stroke treatment in adults can’t necessarily be extrapolated to children.
News
Study supports link between pediatric MS and remote viral infections
BOSTON – Building on previous studies, researchers found several possible associations that could lead to MS.
News
Intensive BP lowering may reduce larger hematoma expansion in ICH
BOSTON – Intensive systolic blood pressure reduction did not significantly reduce hematoma expansion, except in those with larger hematomas.
News
PATH study: Subcutaneous immunoglobulin safe, effective for CIDP maintenance
BOSTON – No differences in relapse recurrence were noted between low and high doses in the randomized, placebo-controlled, phase III study.
News
24/7 neurologist coverage improved community hospital stroke outcomes
BOSTON – The impact of a neurologist available at all times was most significant at night.
News
Cannabidiol cuts drop seizure frequency in Lennox-Gastaut syndrome
BOSTON – Two trials show drop seizure reductions of 37%-44% with cannabidiol in patients with a median of 70-plus drop seizures per month.